Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues

. 2020 ; 12 () : 857-864. [epub] 20200806

Status PubMed-not-MEDLINE Jazyk angličtina Země Nový Zéland Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid32821171

BACKGROUND: Most literature on second primary cancers (SPCs) focuses on possible factors, which may increase the risk of these cancers, and little attention has been paid for the overall incidence differences between first primary cancers (FPCs) and same SPCs. We wanted to compare the incidence rates for all common cancers when these were diagnosed as FPCs and SPCs after invasive and in situ squamous cell carcinoma (SCC) of the skin, which are usually treated by surgery only. METHODS: Cancers were identified from the Swedish Cancer Registry from the years 1990 through to 2015, and they included, in addition to skin cancers, 20 male cancers totaling 484,850 patients and 22 female cancers totaling 452,909 patients. Standardized incidence rates and relative risks (RRs) were calculated for sex-specific common cancers as FPC and as SPC after skin SCC. Spearman rank correlations were used in the analysis of incidence ranking of FPC and SPC. RESULTS: Of total, 29,061 men and 23,533 women developed invasive SCC and 27,842 men and 36,383 women in situ SCC. The total number of 20 other male cancers was 484,850 and of 22 female cancers it was 452,909. Rank correlations ranged from 0.90 to 0.96 (P~5×10-6), indicating that overall skin SCC did not interfere with SPC formation. The exceptions were increased SPC risks for melanoma, sharing risk factors with skin SCC, and non-Hodgkin and Hodgkin lymphoma, and cancers of the upper aerodigestive tract, connective tissue, and male and female genitals suggesting contribution by skin cancer initiated immune dysfunction. CONCLUSION: The incidence ranking of SPCs after skin cancers largely follows the incidence ranking of FPCs indicating that overall skin SCC does not greatly interfere with the intrinsic carcinogenic process. The main deviations in incidence between FPC and SPC appeared to be due to shared risk factors or immunological processes promoting immune responsive cancer types.

Zobrazit více v PubMed

Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours: challenges and approaches, a review. PubMed DOI PMC

Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. PubMed DOI

Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship–genetic susceptibility and second primary cancers: research strategies and recommendations. PubMed DOI

Chattopadhyay S, Zheng G, Hemminki O, Forsti A, Sundquist K, Hemminki K. Prostate cancer survivors: risk and mortality in second primary cancers. PubMed DOI PMC

Chattopadhyay S, Hemminki A, Försti A, Sundquist K, Sundquist J, Hemmiinki K. Familial risks and mortality in second primary cancers in melanoma. PubMed DOI PMC

Chattopadhyay S, Hemminki O, Forsti A, Sundquist K, Sundquist J, Hemminki K. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer. PubMed

Centre for Epidemiology.

Green AC, Olsen CM. Cutaneous squamous cell carcinoma: an epidemiological review. PubMed DOI

IARC.

Omland SH, Ahlstrom MG, Gerstoft J, et al. Risk of skin cancer in patients with HIV: a Danish nationwide cohort study. PubMed DOI

Hortlund M, Arroyo Muhr LS, Storm H, Engholm G, Dillner J, Bzhalava D. Cancer risks after solid organ transplantation and after long-term dialysis. PubMed DOI

Harwood CA, Toland AE, Proby CM, et al. The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients. PubMed DOI

Bottomley MJ, Thomson J, Harwood C, Leigh I. The role of the immune system in cutaneous squamous cell carcinoma. PubMed DOI PMC

Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. PubMed DOI

Pukkala E, Engholm G, Hojsgaard Schmidt LK, et al. Nordic cancer registries - an overview of their procedures and data comparability. PubMed DOI

Chen T, Fallah M, Brenner H, et al. Risk of second primary cancers in multiple myeloma survivors in german and swedish cancer registries. PubMed DOI PMC

Chen T, Fallah M, Jansen L, et al. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. PubMed DOI

Chattopadhyay S, Hemminki A, Forsti A, Sundquist K, Sundquist J, Hemminki K. Second primary cancers in patients with invasive and in situ squamous cell skin carcinoma, Kaposi sarcoma and Merkel cell carcinoma: role for immune mechanisms? PubMed

Chattopadhyay S, Sud A, Zheng G, et al. Second primary cancers in non-Hodgkin lymphoma: bi-directional analyses suggesting role for immune dysfunction. PubMed DOI

Hemminki K, Hemminki O, Försti A, Sundquist K, Sundquist J, Li X. Surveillance bias in cancer risk after unrelated medical conditions: example urolithiasis. PubMed DOI PMC

Emens LA, Ascierto PA, Darcy PK, et al. Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape. PubMed DOI

Rama I, Grinyo JM. Malignancy after renal transplantation: the role of immunosuppression. PubMed DOI

Harms PW, Harms KL, Moore PS, et al. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. PubMed DOI PMC

Rangwala S, Tsai KY. Roles of the immune system in skin cancer. PubMed DOI PMC

Zur Hausen H. The search for infectious causes of human cancers: where and why. PubMed DOI

IARC. Biological agents. Volume 100 B. A review of human carcinogens. PubMed PMC

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace